{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:18:39Z","timestamp":1770290319687,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.7759\/cureus.45105","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T14:58:50Z","timestamp":1694530730000},"source":"Crossref","is-referenced-by-count":2,"title":["End-Organ Damage in Hypertension: An Insight on a Differentiated Outpatient Consultation"],"prefix":"10.7759","author":[{"given":"Rui","family":"Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Caridade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.06.048","article-title":"Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review","volume":"127","author":"Meng L","year":"2021","unstructured":"Meng L. Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review. Br J Anaesth. 2021, 127:845-61. 10.1016\/j.bja.2021.06.048","journal-title":"Br J Anaesth"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i5.227","article-title":"Management of hypertension in primary aldosteronism","volume":"6","author":"Aronova A","year":"2014","unstructured":"Aronova A, Fahey TJ II, Zarnegar R. Management of hypertension in primary aldosteronism. World J Cardiol. 2014, 6:227-33. 10.4330\/wjc.v6.i5.227","journal-title":"World J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00759.2016","article-title":"A pathogenic role of complement in arterial hypertension and hypertensive end organ damage","volume":"312","author":"Wenzel UO","year":"2017","unstructured":"Wenzel UO, Bode M, K\u00f6hl J, Ehmke H. A pathogenic role of complement in arterial hypertension and hypertensive end organ damage. Am J Physiol Heart Circ Physiol. 2017, 312:H349-54. 10.1152\/ajpheart.00759.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IBPC.S34425","article-title":"Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure","volume":"6","author":"Danyel LA","year":"2013","unstructured":"Danyel LA, Schmerler P, Paulis L, Unger T, Steckelings UM. Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr Blood Press Control. 2013, 6:153-61. 10.2147\/IBPC.S34425","journal-title":"Integr Blood Press Control"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2017.65","article-title":"Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?","volume":"40","author":"Nehme A","year":"2017","unstructured":"Nehme A, Zibara K. Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?. Hypertens Res. 2017, 40:903-9. 10.1038\/hr.2017.65","journal-title":"Hypertens Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira NS","year":"2021","unstructured":"Ferreira NS, Tostes RC, Paradis P, Schiffrin EL. Aldosterone, inflammation, immune system, and hypertension. Am J Hypertens. 2021, 34:15-27. 10.1093\/ajh\/hpaa137","journal-title":"Am J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension","volume":"17","author":"Mu\u00f1oz-Durango N","year":"2016","unstructured":"Mu\u00f1oz-Durango N, Fuentes CA, Castillo AE, Gonz\u00e1lez-G\u00f3mez LM, Vecchiola A, Fardella CE, Kalergis AM. Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int J Mol Sci. 2016, 17:797. 10.3390\/ijms17070797","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone S","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018, 6:41-50. 10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster WG","year":"2015","unstructured":"McMaster WG, Kirabo A, Madhur MS, Harrison DG. Inflammation, immunity, and hypertensive end-organ damage. Circ Res. 2015, 116:1022-33. 10.1161\/CIRCRESAHA.116.303697","journal-title":"Circ Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i9.890","article-title":"Metabolic syndrome in hypertensive patients: an unholy alliance","volume":"6","author":"Mul\u00e8 G","year":"2014","unstructured":"Mul\u00e8 G, Calcaterra I, Nardi E, Cerasola G, Cottone S. Metabolic syndrome in hypertensive patients: an unholy alliance. World J Cardiol. 2014, 6:890-907. 10.4330\/wjc.v6.i9.890","journal-title":"World J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/171238-end-organ-damage-in-hypertension-an-insight-on-a-differentiated-outpatient-consultation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:45Z","timestamp":1707508425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/171238-end-organ-damage-in-hypertension-an-insight-on-a-differentiated-outpatient-consultation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.45105","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}